Geode Capital Management LLC decreased its position in Shire PLC (NASDAQ:SHPG) by 14.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 49,279 shares of the biopharmaceutical company’s stock after selling 8,650 shares during the quarter. Geode Capital Management LLC’s holdings in Shire were worth $8,575,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. United Services Automobile Association lifted its stake in Shire by 2.2% in the 3rd quarter. United Services Automobile Association now owns 16,267 shares of the biopharmaceutical company’s stock worth $2,949,000 after purchasing an additional 354 shares in the last quarter. Kepos Capital LP lifted its stake in Shire by 400.0% in the 3rd quarter. Kepos Capital LP now owns 425,000 shares of the biopharmaceutical company’s stock worth $77,040,000 after purchasing an additional 340,000 shares in the last quarter. Pacer Advisors Inc. lifted its stake in Shire by 13.4% in the 3rd quarter. Pacer Advisors Inc. now owns 6,452 shares of the biopharmaceutical company’s stock worth $1,170,000 after purchasing an additional 761 shares in the last quarter. APCM Wealth Management for Individuals purchased a new stake in Shire in the 3rd quarter worth $393,000. Finally, Alpine Global Management LLC purchased a new stake in Shire in the 3rd quarter worth $5,438,000. 20.23% of the stock is owned by institutional investors.

Shire stock opened at $179.20 on Tuesday. Shire PLC has a twelve month low of $123.73 and a twelve month high of $182.47. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.51 and a current ratio of 0.92. The stock has a market capitalization of $54.71 billion, a PE ratio of 11.83, a price-to-earnings-growth ratio of 1.54 and a beta of 0.87.

Several analysts have commented on SHPG shares. Cantor Fitzgerald set a $222.00 price target on shares of Shire and gave the stock a “buy” rating in a research note on Thursday, December 20th. BidaskClub upgraded shares of Shire from a “hold” rating to a “buy” rating in a report on Tuesday, December 25th. Finally, William Blair downgraded shares of Shire from an “outperform” rating to a “market perform” rating in a report on Thursday, December 20th. Seven equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $201.60.

WARNING: “Geode Capital Management LLC Sells 8,650 Shares of Shire PLC (SHPG)” was originally reported by Daily Political and is the property of of Daily Political. If you are reading this news story on another domain, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this news story can be viewed at https://www.dailypolitical.com/2019/04/16/geode-capital-management-llc-sells-8650-shares-of-shire-plc-shpg.html.

Shire Profile

Shire plc, a biotechnology company, researches, develops, licenses, manufactures, markets, distributes, and sells medicines for rare diseases and other specialized conditions worldwide. The company offers products in therapeutic areas, including hematology, genetic diseases, neuroscience, immunology, internal medicine, ophthalmology, and oncology.

Featured Story: Total Return

Want to see what other hedge funds are holding SHPG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Shire PLC (NASDAQ:SHPG).

Institutional Ownership by Quarter for Shire (NASDAQ:SHPG)

Receive News & Ratings for Shire Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire and related companies with MarketBeat.com's FREE daily email newsletter.